Medtronic Accounts Receivable decreased by 0.5% to $6.36B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.0%, from $6.12B to $6.36B. Over 4 years (FY 2021 to FY 2025), Accounts Receivable shows an upward trend with a 4.5% CAGR.
An increase relative to sales may signal slowing collections or credit risk, while a decrease suggests efficient cash conversion.
The total amount of credit extended to customers and channel partners for products sold or services rendered, minus an a...
Typically scales with revenue growth; however, companies with strong direct-to-consumer channels may have lower receivables relative to those relying on third-party distributors.
accounts_receivable_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.43B | $5.49B | $5.45B | $5.55B | $5.31B | $5.63B | $5.89B | $6.00B | $5.81B | $5.93B | $5.97B | $6.13B | $6.01B | $6.26B | $6.12B | $6.52B | $6.26B | $6.39B | $6.36B |
| QoQ Change | — | +1.1% | -0.9% | +1.9% | -4.4% | +6.0% | +4.6% | +1.9% | -3.2% | +2.2% | +0.6% | +2.7% | -1.9% | +4.1% | -2.3% | +6.5% | -3.9% | +2.0% | -0.5% |
| YoY Change | — | — | — | — | -2.3% | +2.4% | +8.1% | +8.1% | +9.4% | +5.5% | +1.4% | +2.2% | +3.5% | +5.5% | +2.5% | +6.3% | +4.2% | +2.1% | +4.0% |